RxDoctor Payments DataLook up a doctor →

James Katz, MD

Ophthalmology · Des Plaines, ILNPI 1477587509

Payments from drug & device makers

$708,168in general payments, 2019–2025

Across 876 payments — averaging $808.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$201K
  • Tarsus Pharmaceuticals, Inc.$113K
  • Novartis$110K
  • Bausch & Lomb Americas Inc.$104K
  • Alcon$86K
  • Carl Zeiss Meditec, Inc.$21K
  • plus $72K from 34 others
$9,417in research payments, 2019–2025

Across 3 payments — averaging $3138.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$7K
  • Oyster Point Pharma, Inc.$2K
  • Novartis Pharma AG$750

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$708,168 in reported general payments places this provider in the 95th percentile of 773 ophthalmology providers in Illinois.

See all ophthalmology providers in Illinois

Medicare billing

Part B allowed, 2024
$433,078
Medicare patients
1,180
Services billed
3,686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Des Plaines

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →